Journal of Embryo Transfer (한국수정란이식학회지)

The Korean Society of Embryo Transfer (한국수정란이식학회)
권호 표지

Activation of Caspase-3 and -7 on Porcine Bone Marrow Derived Mesenchymal Stem Cells (pBM-MSCs) Cryopreserved with Dimethyl Sulfoxide (DMSO)

동결 보호제(DMSO) 농도에 따른 돼지 중간엽 줄기세포의 Caspase 3과 7 발현

  • Ock, Sun-A (Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration) ;
  • Rho, Gyu-Jin (OBS/Theriogenology and Biotechnology, College of Veterinary Medicine, Gyeongsang National University)
  • 옥선아 (국립축산과학원 바이오공학과) ;
  • 노규진 (국립경상대학교 수의과대학 수의산과학연구실)
  • Received : 2012.08.17
  • Accepted : 2012.08.30
  • Published : 2012.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Adult stem cell transplantation has been increased every year, because of the lack of organ donors for regenerative medicine. Therefore, development of reliable and safety cryopreservation and bio-baking method for stem cell therapy is urgently needed. The present study investigated safety of dimethyl sulfoxide (DMSO) such as common cryoprotectant on porcine bone marrow derived mesenchymal stem cells (pBM-MSCs) by evaluating the activation of Caspase-3 and -7, apoptosis related important signal pathway. pBM-MSCs used for the present study were isolated density gradient method by Ficoll-Paque Plus and cultured in A-DMEM supplemented 10% FBS at $38.5^{\circ}C$ in 5% $CO_2$ incubator. pBM-MSCs were cryopreserved in A-DMEM supplemented either with 5%, 10% or 20% DMSO by cooling rate at $-1^{\circ}C$/min in a Kryo 360 (planner 300, Middlesex, UK) and kept into $LN_2$. Survival rate of cells after thawing did not differ between 5% and 10% DMSO but was lowest in 20% DMSO by 0.4% trypan blue exclusion. Activation of Caspase-3 and -7 by Vybrant FAM Caspase-3 and -7 Assay Assay Kit (Molecular probes, Inc.OR, USA) was analyzed with a flow cytometer. Both of cryopreserved and control groups (fresh pBM-MSCs) were observed after the activation of Caspase-3 and -7. The activation did not differ between 5% and 10% DMSO, but was observed highest in 20% DMSO. Therefore 5% DMSO can be possibly used for cell cryopreservation instead of 10% DMSO.

Keywords

References

  1. Aldahmash A, Zaher W, Al-Nbaheen and Kassem M. 2012. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration. Ann. Saudi.Med. 32:68-77. https://doi.org/10.5144/0256-4947.2012.68
  2. Bedner E, Smolewski P, Amstad P and Darzynkiewicz Z. 2000. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp. Cell Res. 259: 308-313. https://doi.org/10.1006/excr.2000.4955
  3. Bhandari DR, Seo KW, Sun B, Seo MS, Kim HS, Seo YJ, Marcin J, Forraz N, Roy HL, Larry D, Colin M and Kang KS. 2011. The simplest method for in vitro $\beta$-cell production from human adult stem cells. Differentiation 82: 144-152. https://doi.org/10.1016/j.diff.2011.06.003
  4. Davis J, Rowley SD and Santos GW. 1990. Toxicity of autologous bone marrow graft infusion. Prog. Clin. Biol. Res. 333:531-540.
  5. Faast R, Harrison SJ, Beebe LF, McIlfatrick SM, Ashman R and Nottle MB. 2006. Use of adult mesenchymal stem cells isolated from bone marrow and blood for somatic cell nuclear transfer in pigs. Cloning Stem Cells 8:166-173. https://doi.org/10.1089/clo.2006.8.166
  6. Kamata M, Liang M, Liu S, Nagaoka Y and Chen IS. 2010. Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs. PLoS One. 5:e11834. https://doi.org/10.1371/journal.pone.0011834
  7. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R and Kim KS. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cel. 54:472-476
  8. Magatti M, De Munari S, Vertua E, Gibelli L, Wengler GS and Parolini O. 2008. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192. https://doi.org/10.1634/stemcells.2007-0491
  9. Ock SA, Jeon BG and Rho GJ. 2010. Comparative characterization of porcine mesenchymal stem cells derived from bone marrow extract and skin tissues. Tissue Eng. Part C Methods. 161:481-491.
  10. Ogawa T, Ono S, Ichikawa T, Arimitsu S, Onoda K, Tokunaga K, Sugiu K, Tomizawa K, Matsui H, and Date I. 2007. Novel protein transduction method by using 11R: an effective new drug delivery system for the treatment of cerebrovascular diseases. Stroke 38:1354-1361. https://doi.org/10.1161/01.STR.0000259887.70358.e0
  11. Robertson JA. 2010. Embryo stem cell research: ten years of controversy. J. Law. Med. Ethics 38:191-203. https://doi.org/10.1111/j.1748-720X.2010.00479.x
  12. Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lønning PE, Bjerkvig R and Schichor C. 2009. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 69:5331-5339. https://doi.org/10.1158/0008-5472.CAN-08-4630
  13. Sarkis C, Philippe S, Mallet J and Serguera C. 2008. Non-integrating lentiviral vectors. Curr. Gene Ther. 8:430-437. https://doi.org/10.2174/156652308786848012
  14. Smolewski P, Grabarek J, Halicka H and Darzynkiewicz Z. 2002. Assay of caspase activation in situ combined with probing plasma membrane integrity to detect three distinct stages of apoptosis. J. Immunol. Methods 265:111-121. https://doi.org/10.1016/S0022-1759(02)00074-1
  15. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson DW. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907-17911. https://doi.org/10.1074/jbc.272.29.17907
  16. Tsukiyama T, Asano R, Kawaguchi T, Kim N, Yamada M, Minami N, Ohinata Y and Imai H. 2011. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system. Genes Cells 16:815-825 https://doi.org/10.1111/j.1365-2443.2011.01528.x
  17. Vishnubalaji R, Al-Nbaheen M, Kadalmani B, Aldahmash A and Ramesh T. 2012. Skin-derived multipotent stromal cells - an archrival for mesenchymal stem cells. Cell Tissue Res. In press.
  18. Yamanaka S. 2007. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 1:39-49. Review. https://doi.org/10.1016/j.stem.2007.05.012
  19. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P and Robustelli della Cuna G. 1998. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 18:4705-4708.
  20. Zeisberger SM, Schulz JC, Mairhofer M, Ponsaerts P, Wouters G, Doerr D, Katsen-Globa A, Ehrbar M, Hescheler J, Hoerstrup SP, Zisch AH, Kolbus A and Zimmermann H. 2011.Biological and physicochemical characterization of a serumand xeno-free chemically defined cryopreservation procedure for adult human progenitor cells. Cell Transplant. 20: 1241-1257. https://doi.org/10.3727/096368910X547426